In this study, a panel of seven autoantibodies (including p53, PGP9.5, SOX2, GAGE7, GBU4-5, MAGEA1, and CAGE) were measured in the plasma of lung cancer patients and healthy controls to test the diagnostic value. This evidence concerns the gene TP53 and lung cancer.